ReShape Lifesciences announces pending merger with Vyome Therapeutics; ticker to change to $HIND

Vyome Holdings, Inc

Merger with Vyome Therapeutics Inc. and asset sale to Biorad Medisys or affiliate.
Ticker symbol to change from RSLS to HIND upon closing.
Investor presentation furnished as Exhibit 99.1, highlighting clinical-stage immunoinflammation assets.
No specific deal value or premium disclosed in this filing.
Approval required from ReShape stockholders; joint proxy statement/prospectus to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.